UK markets open in 1 hour 56 minutes
NIKKEI 225
38,800.90 +564.83 (+1.48%) HANG SENG
18,420.38 -157.92 (-0.85%) CRUDE OIL
78.62 +0.14 (+0.18%) GOLD FUTURES
2,331.40 +0.20 (+0.01%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,533.94 -570.66 (-1.12%)
Catalyst Pharmaceuticals, Inc. (CPRX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 14.72 |
| Open | 14.82 |
| Bid | 14.97 x 200 |
| Ask | 15.00 x 200 |
| Day's range | 14.68 - 15.00 |
| 52-week range | 11.09 - 17.74 |
| Volume | |
| Avg. volume | 1,342,085 |
| Market cap | 1.769B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 23.79 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
Catalyst (CPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
Key Insights Given the large stake in the stock by institutions, Catalyst Pharmaceuticals' stock price might be...
© 2024 Yahoo. All rights reserved.